The estimated Net Worth of Omid Farokhzad is at least $106 Million dollars as of 7 March 2024. Dr Farokhzad owns over 52,857 units of Seer stock worth over $2,312,419 and over the last 8 years he sold SEER stock worth over $102,862,033. In addition, he makes $972,082 as CEO & Chair of the Board of Directors at Seer.
Sign up
Dr D SEER stock SEC Form 4 insiders trading
Dr has made over 13 trades of the Seer stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 52,857 units of SEER stock worth $107,300 on 7 March 2024.
The largest trade he's ever made was selling 1,089,279 units of Seer stock on 3 December 2020 worth over $69,877,248. On average, Dr trades about 114,741 units every 106 days since 2016. As of 7 March 2024 he still owns at least 1,436,285 units of Seer stock.
You can see the complete history of Dr Farokhzad stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Omid C. Farokhzad Ph.D., M.D. biography
Dr. Omid C. Farokhzad Ph.D., M.D. is the CEO & Chair of the Board of Directors at Seer.
What is the salary of Dr D?
As the CEO & Chair of the Board of Directors of Seer, the total compensation of Dr D at Seer is $972,082. There are no executives at Seer getting paid more.
How old is Dr D?
Dr D is 51, he's been the CEO & Chair of the Board of Directors of Seer since . There are 3 older and 1 younger executives at Seer. The oldest executive at Seer, Inc. is David R. Horn, 53, who is the Exec. VP & Chief Financial Officer.
What's Dr D's mailing address?
Omid's mailing address filed with the SEC is C/O SEER, INC., 3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065.
Insiders trading at Seer
Over the last 7 years, insiders at Seer have traded over $150,878,393 worth of Seer stock and bought 1,798,420 units worth $33,507,980 . The most active insiders traders include Omid Farokhzad, Terrance Mcguire und Growth Fund Limited Partner.... On average, Seer executives and independent directors trade stock every 60 days with the average trade being worth of $227,813. The most recent stock trade was executed by Dipchand Nishar on 14 June 2024, trading 12,109 units of SEER stock currently worth $21,554.
What does Seer do?
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
What does Seer's logo look like?
Complete history of Dr Farokhzad stock trades at Selecta Biosciences Inc und Seer
Seer executives and stock owners
Seer executives and other stock owners filed with the SEC include:
-
Dr. Omid C. Farokhzad M.D., Ph.D.,
Founder, CEO & Chair of the Board of Directors -
Dr. Omid C. Farokhzad Ph.D., M.D.,
CEO & Chair of the Board of Directors -
Omead Ostadan,
Part Time Pres, COO & Director -
David R. Horn,
Exec. VP & Chief Financial Officer -
Martin Goldberg Ph.D.,
Sr. VP of Devel. -
Elona Kogan Esq., J.D.,
Gen. Counsel & Sec. -
Marissa Dixon,
VP & Chief People Officer -
Jennifer Maggio,
VP & Corp. Controller -
Dr. Serafim Batzoglou,
VP & Chief of Computation -
Shashanka Muppaneni,
VP of Corp. Devel. -
Karen Possemato,
VP of Corp. Marketing & Communications -
Elona Kogan J.D., Esq.,
Gen. Counsel & Sec. -
Dr. Philip Ma Ph.D.,
Founder & Strategic Advisor -
Joe Laws,
Chief Technology Officer and Co-Founder -
David Hallal,
-
Rachel E. Haurwitz,
-
Dipchand Nishar,
-
Mostafa Ronaghi,
Director -
David B Singer,
Director -
Public Equities, L.P.Invus ...,
-
Omead Ostadan,
President & COO -
David R. Horn,
PRESIDENT & CFO -
Growth Fund Limited Partner...,
-
Capital Ventures, Llc Maver...,
-
Cathy Friedman,
Director -
Terrance Mcguire,
-
Capital Ventures, Llc Maver...,
-
Robert Langer,
-
Scott D Thomas,
Chief Commercial Officer -
Public Equities, L.P.Artal ...,
-
Meeta Gulyani,
-
Omid Farokhzad,
CEO AND CHAIR -
Elona Kogan,
CHIEF LEGAL OFFICER -
Nicolas H Phd Roelofs,